医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

KILL Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit

2020年11月13日 PM12:23
このエントリーをはてなブックマークに追加


 

Illumina, Inc. requests that their press release NewsItemId: 20201112005379 “Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit” be removed.

CONTACT

Business Wire, Los Angeles

310-820-9473

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Sherlock Biosciences Strengthens Intellectual Property Portfolio in CRISPR-based Diagnostics Through Exclusive License Agreement with Tolo Biotech
  • New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint
  • Shape Therapeutics推出AAVid™衣壳发现平台和新型组织特异性AAV变异识别,解决基因治疗根本性的投药挑战
  • 三叶草生物发布其“S-三聚体”重组亚单位新冠候选疫苗 I 期临床研究积极结果
  • Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates